Case Studies

An NIH study of treatments for high blood pressure, called the ALLHAT trial, shows some of the strengths and limitations of comparative effectiveness research to improve patient care. More...

Recent Blog Posts

September 3, 2010 |

Partnership to Improve Patient Care (PIPC) Chairman Tony Coelho was quoted in an Inside Health Policy article this week discussing his concerns on the Department of Health and Human Service’s (HHS) plans to build a CER inventory before the creation of the Patient Centered Outcomes and Research Institute, an independent board that will facilitate CER research.

| Read More
September 3, 2010 |

The latest addition of Congressional Quarterly (CQ) features an article on comparative effectiveness research (CER) in which Partnership to Improve Patient Care (PIPC) Chairman Tony Coelho weighs in on the issue.

| Read More
August 16, 2010 |

Partnership to Improve Patient Care Chairman Tony Coelho recently sent a letter to Sherry Glied, the Assistant Secretary for Planning and Evaluation at the Department of Health and Human Services (HHS), recommending that the Agency work closely with the Patient Centered Outcomes and Research Institute when building its planned nationwide CER database.

| Read More

For Reporters

For journalists and other media professionals

More Information

Stay Connected

preventive services task force

Lack of support for "evidence-based health care"— don't blame the patient

| Posted in:

A new Health Affairs article concludes, based on focus groups and interviews, that "consumers will revolt if evidence-based efforts are perceived as rationing or as a way to deny them needed treatment."

You don't need to look any further than public reaction to the U.S. Preventive Service Task Force's updated recommendations on mammography screening to see the proof of this.
 
How should policy-makers react? Should they conclude that consumers, and even more so, patients, cannot be relied on to make evidence-based decisions, and therefore these decisions need to be made for them? Or should they conclude that evidence-based models of medical care and health delivery need to be carefully constructed so they have the trust and support of patients and consumers?

Syndicate content